Høeg’s appointment to director of the FDA's CDER follows a turbulent period for the department, which has seen five leaders ...
Formosa Pharmaceuticals and Rxilient Medical have agreed on the commercialisation of APP13007 in ASEAN markets.
Eli Lilly and Company has received approval from the US FDA for the expanded use of Jaypirca tablets in 100mg and 50mg doses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback